Also trades as: RENE.L (LSE) · $vol 0M
RNUGF OTC
ReNeuron Group plc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.5%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$7M
-1.0% ▼
Capital Expenditures
$220K
+27.2% ▲
5Y CAGR: -1.3%
Free Cash Flow
-$8M
+0.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$3M
+34.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$17M | -$14M | -$13M | -$11M | -$7M |
| Depreciation & Amort. | $282K | $412K | $380K | $324K | $267K |
| Stock-Based Comp. | $1M | $1M | $764K | $649K | $576K |
| Change in Working Capital | $2M | -$857K | -$307K | $1M | -$3M |
| Other Non-Cash Items | -$1M | -$551K | $496K | -$170K | $978K |
| Operating Cash Flow | -$12M | -$14M | -$6M | -$7M | -$7M |
| — Investing Activities — | |||||
| Capital Expenditures | -$188K | -$119K | -$25K | -$302K | -$220K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $2M | $4M |
| Other Investing | $342K | $300K | $27K | -$2M | $131K |
| Investing Cash Flow | $154K | $181K | $2K | -$276K | $4M |
| — Financing Activities — | |||||
| Net Debt Issuance | $4M | $6M | -$154K | -$157K | -$148K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $6K | -$132K | -$9M | $2M | $0 |
| Financing Cash Flow | $4M | $6M | $9M | $2M | -$147K |
| Net Change in Cash | -$7M | -$8M | $2M | -$5M | -$3M |
| Cash End of Period | $20M | $13M | $15M | $10M | $6M |
| Free Cash Flow | -$12M | -$14M | -$6M | -$8M | -$8M |